Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.15357 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.13724 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.137 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.09166 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.09172 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.5129 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.23398 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.11896 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.22237 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.1264 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.12212 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.10877 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.18832 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.12705 | 6 |